公开(公告)号：US10227406B2

公开(公告)日：2019-03-12

申请号：US14899551

申请日：2014-06-25

申请人： AMGEN INC.

发明人： Peter Coward ,  Steven A. Moore, Jr. ,  Shi-Yuan Meng ,  Mei-Mei Tsai ,  Chadwick Terence King ,  Aaron Avraham Nazarian

IPC分类号： C07K16/28

摘要： This disclosure relates to CB1 receptor antigen-binding proteins, e.g. antibodies and methods of using the CB1 receptor antibodies. The CB1 receptor antibodies may comprise an antagonistic antibody to CB1 receptors and may be used to treat various health conditions. The health conditions can comprise obesity or diabetes or any disease that benefits from antagonism of the CB1 receptor.